SECOND Amendment to BUSINESS COMBINATION AGREEMENTBusiness Combination Agreement • January 3rd, 2022 • Capstar Special Purpose Acquisition Corp. • Pharmaceutical preparations
Contract Type FiledJanuary 3rd, 2022 Company IndustryThis Second Amendment to the Business Combination Agreement (this “Amendment”) is entered into as of December 30, 2021 (the “Amendment Effective Date”), by and among Capstar Special Purpose Acquisition Corp., a Delaware corporation (“Capstar”), CPSR Gelesis Merger Sub, Inc., a Delaware corporation (“Merger Sub”), and Gelesis, Inc., a Delaware corporation (the “Company”).
BACKSTOP AGREEMENTBackstop Agreement • January 3rd, 2022 • Capstar Special Purpose Acquisition Corp. • Pharmaceutical preparations • New York
Contract Type FiledJanuary 3rd, 2022 Company Industry JurisdictionThis Backstop Agreement (this “Agreement”) is entered into as of December 30, 2021, by and between Capstar Special Purpose Acquisition Corp., a Delaware corporation (the “Company”), PureTech Health LLC (“PureTech”) and SSD2, LLC (“SSD2” and together with PureTech, the “Purchasers”, and each a “Purchaser”). Capitalized terms used but not defined herein shall have the respective meanings ascribed to such terms in the Business Combination Agreement (as defined below).